EIF4EBP1 and astrocytoma (excluding glioblastoma): Among IDH-mutant gliomas, there was no difference in EIF4EBP1 expression levels in 1p/19q-codeleted oligodendrogliomas versus 1p/19q-intact astrocytomas included in the FRENCH cohort dataset [28] (Fig. S1H) or TCGA dataset [32] (Fig. S1I).